Drug-Drug Interactions in Pharmaceutical Development
Binghe Wang
€ 125.18
FREE Delivery in Ireland
Description for Drug-Drug Interactions in Pharmaceutical Development
Hardcover. Drug-Drug Interactions in Pharmaceutical Development comprehensively reviews the relevant science, industrial practice, and regulatory agency positions on drug-drug interactions. It focuses on the evaluation of potential drug-drug interactions, allowing researchers to address risk factors before a drug is put to market. Editor(s): Li, Albert P. Series: Wiley Series in Drug Discovery and Development. Num Pages: 244 pages, Illustrations. BIC Classification: MMG; PNN. Category: (P) Professional & Vocational. Dimension: 235 x 164 x 22. Weight in Grams: 582.
Drug-Drug Interactions in Pharmaceutical Development comprehensively reviews the relevant science, industrial practice, and regulatory agency positions on drug-drug interactions. It focuses on the evaluation of potential drug-drug interactions, allowing researchers to address risk factors before a drug is put to market. The book covers both clinical and nonclinical aspects for understanding drug-drug interactions as well as in vitro and in vivo studies for use in studying interactions at the drug discovery stage.
Drug-Drug Interactions in Pharmaceutical Development comprehensively reviews the relevant science, industrial practice, and regulatory agency positions on drug-drug interactions. It focuses on the evaluation of potential drug-drug interactions, allowing researchers to address risk factors before a drug is put to market. The book covers both clinical and nonclinical aspects for understanding drug-drug interactions as well as in vitro and in vivo studies for use in studying interactions at the drug discovery stage.
Product Details
Format
Hardback
Publication date
2007
Publisher
John Wiley and Sons Ltd United Kingdom
Number of pages
244
Condition
New
Series
Wiley Series in Drug Discovery and Development
Number of Pages
264
Place of Publication
, United States
ISBN
9780471794417
SKU
V9780471794417
Shipping Time
Usually ships in 7 to 11 working days
Ref
99-1
About Binghe Wang
Albert P. Li is the President and CEO of In Vitro ADMET Laboratories, LLC (www.invitroadmet.com), and Advanced Pharmaceutical Sciences, Inc. (www.apsciences.com), and the cofounder, Chairman, and CSO of the ADMET Group (www.admetgroup.com). Dr. Li has over twenty-five years in the drug development industry, is a distinguished international speaker in the field, and has over 150 publications. He has edited several ... Read more
Reviews for Drug-Drug Interactions in Pharmaceutical Development
"I am pleased to have read this book from cover-to-cover. I will value owning it and keep it near the front of my bookshelf" (Good Clinical Practice Journal, June 2008)